Literature DB >> 11824205

Endocrine physiology in a patient-centered learning curriculum.

R C Vari1, K E Borg, V L McCleary, J T McCormack, K G Ruit, K A Sukalski, L M Olson.   

Abstract

The medical curriculum at the University of North Dakota School of Medicine and Health Sciences has recently been redesigned into a problem-based/traditional hybrid model that utilizes an integrated organ systems-based approach to teach basic and clinical sciences. The number of lecture hours in general has been greatly reduced, and, in particular, lecture hours in physiology have been reduced by 65%. Students learn basic science in small groups led by a faculty facilitator, and students are responsible for a great deal of their own teaching and learning. The curriculum is centered around patient cases and is called patient-centered learning (PCL). The curriculum includes traditional lectures and laboratories supporting faculty-generated learning objectives. Endocrine physiology is taught in year one, utilizing four weeks of patient cases that emphasize normal structure and function of endocrine systems. Endocrine physiology is revisited in year two, which is primarily focused on pathobiology. The PCL curriculum, with emphasis on the endocrine component, is described in detail along with key portions of an endocrine case.

Entities:  

Mesh:

Year:  2001        PMID: 11824205     DOI: 10.1152/advances.2001.25.4.241

Source DB:  PubMed          Journal:  Adv Physiol Educ        ISSN: 1043-4046            Impact factor:   2.288


  2 in total

1.  Attitude of medical students towards Early Clinical Exposure in learning endocrine physiology.

Authors:  Solomon Sathishkumar; Nihal Thomas; Elizabeth Tharion; Nithya Neelakantan; Rashmi Vyas
Journal:  BMC Med Educ       Date:  2007-09-05       Impact factor: 2.463

2.  Physiology education for intensive care medicine residents: A 15-minute interactive peer-led flipped classroom session.

Authors:  Bjoern Zante; Wolf E Hautz; Joerg C Schefold
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.